Align 4-guanidinobutyraldehyde dehydrogenase (EC 1.2.1.54) (characterized)
to candidate WP_010529728.1 ON01_RS04100 betaine-aldehyde dehydrogenase
Query= metacyc::MONOMER-11560 (497 letters) >NCBI__GCF_000224785.1:WP_010529728.1 Length = 489 Score = 365 bits (937), Expect = e-105 Identities = 197/474 (41%), Positives = 295/474 (62%), Gaps = 6/474 (1%) Query: 21 RAFINGEYTDAVSGETFECLSPVDGRFLAKVASCDLADANRAVENARATFNSGVWSQLAP 80 + I+G + + S + ++P + + +A V D +D A+ AR F+ G W+ Sbjct: 5 KQLIDGSWVTSNSDAVRDIINPFNQKIVATVTESDESDTKAAITAARKAFDQGDWATTPA 64 Query: 81 AKRKAKLIRFADLLRKNVEELALLETLDMGKPIGDSSSIDIPGAAQAIHWTAEAIDKVYD 140 A+R + + ADL+ ++ EELA LE+LD GK + +S D+ A + AE DK Sbjct: 65 AERGKIVHKIADLIERDREELAELESLDTGKTVEESLG-DMDDIAGVFRYFAEMADKDGG 123 Query: 141 EVAPTP-HDQLGLVTREPVGVVGAIVPWNFPLLMACWKLGPALATGNSVVLKPSEKSPLT 199 E+ +P + V EPVGV G I PWN+PLL A WKL PALA GN++V+KPSE +PLT Sbjct: 124 EIIESPIPNSTSKVVHEPVGVCGQITPWNYPLLQASWKLAPALAAGNTLVMKPSEITPLT 183 Query: 200 AIRIAQLAIEAGIPAGVLNVLPGYGHTVGKALALHMDVDTLVFTGSTKIAKQLMVYAGES 259 +I++ +L EAG+PAGV+N++ G G +VG L+ + +VD + FTG K++M A S Sbjct: 184 SIKVFELMAEAGVPAGVVNLVLGPGDSVGAELSANDNVDLISFTGGIHTGKKIM-QAASS 242 Query: 260 NMKRIWLEAGGKSPNIVFADAPDLQAAAEAAASAIAFNQGEVCTAGSRLLVERSIKDKFL 319 N+K + LE GGK+PNIVFADA D + A + A +A+ F+ G++C+AG+RL++E SI D F+ Sbjct: 243 NVKNLALELGGKNPNIVFADA-DFETAVDQAMNAVFFHAGQICSAGTRLIIEESIHDAFV 301 Query: 320 PMVVEALKGWKPGNPLDPQTTVGALVDTQQMNTVLSYIEAGHKDGAKLLAGGKR--TLEE 377 +V+ +K K G+ D T +G L+ +N V++Y+E G ++GA + GG R E Sbjct: 302 SAIVDRVKNIKLGSGFDESTQMGPLISEDHLNKVVNYVENGKQEGATVAVGGSRPDDPEL 361 Query: 378 TGGTYVEPTIFDGVTNAMRIAQEEIFGPVLSVIAFDTAEEAVAIANDTPYGLAAGIWTSD 437 G + PTI G T+ MR+ Q+E FGPV++V F T EEAV +AND+ YGL+ G++T+D Sbjct: 362 QNGLFYLPTILTGCTSDMRVVQDEGFGPVITVEKFTTEEEAVRLANDSIYGLSGGVFTND 421 Query: 438 ISKAHKTARAVRAGSVWVNQYDGGDMTAPFGGFKQSGNGRDKSLHALEKYTELK 491 I+KA + +R G+VW+N + AP+GG+KQSG GR+ LE+Y E K Sbjct: 422 IAKAERCVAKLRMGTVWINDVNLYFPHAPWGGYKQSGIGRELGKTGLEEYQETK 475 Lambda K H 0.316 0.132 0.390 Gapped Lambda K H 0.267 0.0410 0.140 Matrix: BLOSUM62 Gap Penalties: Existence: 11, Extension: 1 Number of Sequences: 1 Number of Hits to DB: 588 Number of extensions: 29 Number of successful extensions: 5 Number of sequences better than 1.0e-02: 1 Number of HSP's gapped: 1 Number of HSP's successfully gapped: 1 Length of query: 497 Length of database: 489 Length adjustment: 34 Effective length of query: 463 Effective length of database: 455 Effective search space: 210665 Effective search space used: 210665 Neighboring words threshold: 11 Window for multiple hits: 40 X1: 16 ( 7.3 bits) X2: 38 (14.6 bits) X3: 64 (24.7 bits) S1: 41 (21.6 bits) S2: 52 (24.6 bits)
This GapMind analysis is from Sep 24 2021. The underlying query database was built on Sep 17 2021.
Each pathway is defined by a set of rules based on individual steps or genes. Candidates for each step are identified by using ublast (a fast alternative to protein BLAST) against a database of manually-curated proteins (most of which are experimentally characterized) or by using HMMer with enzyme models (usually from TIGRFam). Ublast hits may be split across two different proteins.
A candidate for a step is "high confidence" if either:
Otherwise, a candidate is "medium confidence" if either:
Other blast hits with at least 50% coverage are "low confidence."
Steps with no high- or medium-confidence candidates may be considered "gaps." For the typical bacterium that can make all 20 amino acids, there are 1-2 gaps in amino acid biosynthesis pathways. For diverse bacteria and archaea that can utilize a carbon source, there is a complete high-confidence catabolic pathway (including a transporter) just 38% of the time, and there is a complete medium-confidence pathway 63% of the time. Gaps may be due to:
GapMind relies on the predicted proteins in the genome and does not search the six-frame translation. In most cases, you can search the six-frame translation by clicking on links to Curated BLAST for each step definition (in the per-step page).
For more information, see:
If you notice any errors or omissions in the step descriptions, or any questionable results, please let us know
by Morgan Price, Arkin group, Lawrence Berkeley National Laboratory